The Brain Cancer Group are pleased to welcome Dr Kelly McKelvey to our research team at The Bill Walsh Cancer Lab. Dr McKelvey is employed as a Post-Doctoral Scientist and will be examining the interactions of brain cancer cells with the inflammatory (immune and blood coagulation) system to improve brain cancer treatment response, and alleviate treatment-induced symptoms.

DR McKelvey’s position is funded by TBCG and Sydney Vital. Please click the link below to see Dr McKelvey’s full profile on our team page https://www.braincancergroup.com.au/about/the-team/